Exco InTouch boasts quadrupled growth

September saw Exco InTouch celebrate its recognition on the Sunday Times Hiscox Tech Track 100

Register for free to listen to this article
Listen with Speechify
NOTTINGHAM, U.K.—September saw Exco InTouch, a provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, celebrate its recognition on the Sunday Times Hiscox Tech Track 100, which ranks Britain’s fastest-growing private technology companies. It’s the second year in a row of such recognition for Exco InTouch and an achievement the company says is built on a “rapid acceleration of turnover,” with sales having quadrupled over the last three years.
Throughout the last few years, Exco says it has used its innovations to modernize patient engagement and data capture solutions for clinical trials and digital health programs globally. Moreover, with the company having cemented pharma partners in both the United States and Europe, and with the market for technology solutions within the clinical research and healthcare markets now rapidly expanding, management believes that company is set for a sustained period of “exponential” growth.
“We have been delighted by the staggering growth which the company has experienced over the last few years. It clearly shows that our innovations are bringing real value to our customers, and I expect the coming years to be equally as explosive,” said Tim Davis, CEO and founder of Exco. “Pharma is well known to be an industry resistant to change and innovation, and for Exco InTouch to have single-handedly built, defined and grown a technology sector within this market is truly remarkable.”
“However,” he continued, “I believe that there is still huge potential for innovation within our market and we are proud to be leading the way with new products such as Gather. We are currently working on many more innovations to help support pharma, healthcare and, crucially, patients, over the next three to five years. We’re on the cusp of a revolution in this sector, and Exco intends to continue to redefine how companies and patients use and engage with technology for the advancement of healthcare.”
In other recent news, the company also in September announced the appointment of Steve Powell as chief operating officer and president. In this newly created position, Powell will be responsible for all aspects of Exco InTouch’s operational delivery, including services and technology.
“To join at such a pivotal time for Exco InTouch and help drive the company’s potential in the mobile technology industry is very exciting,” Powell said. “Exco has developed into an industry leader in its field, and has a long established track record for bringing innovative mobile and digital technology to the clinical and healthcare sectors. With the recent introduction of Gather, the company is set to grow to dominate the market for data capture and patient engagement solutions for clinical research and commercial healthcare programs and I’m looking forward to ensuring its continued success.”
“The recent growth in the eCOA [electronic Clinical Outcome Assessments] market, combined with the continued growth we have experienced here at Exco InTouch in both clinical and commercial markets, has led to the creation of this new position,” explained Davis. “I have personally known Steve for a long time and believe he will be an invaluable addition to our senior management team and board of directors. Steve possesses extensive industry experience and is very much a distinguished veteran of the sector. Indeed, he’s been involved in clinical technology, including eCOA, throughout his career as well as in two private equity transactions and a successful IPO. His skill set and track record of growing small through to large companies makes him the ideal person to head up this team.”
Powell will be based in the company’s North Carolina office in the United States, in part to facilitate his ability to support the organization’s expanding U.S. customer base and develop its global expansion plans.

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN Magazine May 2024

Latest Issue  

• Volume 20 • Issue 3 • May 2024

May 2024

May 2024 Issue